ADC Therapeutics is a commercial-stage company focused on developing antibody drug conjugates (ADCs), with ZYNLONTA approved for treating relapsed or refractory diffuse large B-cell lymphoma. The company operates globally, with headquarters in Switzerland and operations in New Jersey.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.